Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Spinal Cord Stimulation Versus Nerve Blocks and Physical Therapy
This study has been withdrawn prior to recruitment.
Sponsored by: Boston Scientific Corporation
Information provided by: Boston Scientific Corporation
ClinicalTrials.gov Identifier: NCT00414804
  Purpose

The primary objective of this study is to compare the efficacy of SCS using the Precision implantable neurostimulation device and conventional medical treatment (nerve blocks + physical therapy) in subjects with recently-diagnosed Complex Regional Pain Syndrome (CRPS) after some more conservative treatments have failed. There are significant numbers of patients with CRPS in whom conventional treatment is ineffective and SCS is used only as a last resort. If SCS is effective earlier in the treatment continuum, it would provide a much needed treatment alternative and increase awareness of the utility of SCS for this indication. It is also possible that early intervention with SCS may limit disease progression.


Condition Intervention Phase
Complex Regional Pain Syndrome
Chronic Pain
Pain
Device: Precision
Device: Implantable Neurostimulation Device
Phase IV

MedlinePlus related topics: Complex Regional Pain Syndrome
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Dose Comparison, Parallel Assignment, Efficacy Study
Official Title: Spinal Cord Stimulation (SCS) Versus Nerve Blocks and Physical Therapy for Complex Regional Pain Syndrome

Further study details as provided by Boston Scientific Corporation:

Primary Outcome Measures:
  • The primary endpoint is reduction in baseline levels of pain;
  • The primary safety endpoint is the incidence of adverse events during the study period.

Secondary Outcome Measures:
  • Pain severity after 26, 40, and 52 weeks of treatment (for each treatment option) as compared to baseline;
  • Percent of subjects with a 50% or greater reduction in pain;
  • Percent of subjects crossing over to alternative treatment option;
  • Average pain severity;
  • Number of days with moderate to severe pain;
  • Number of days using pain medication for pain;
  • Quality of life;
  • Days lost from work, work productivity loss, and total disability loss.

Enrollment: 0
Study Start Date: December 2006
Detailed Description:

Standard medical treatment for moderate/severe chronic pain of Complex Regional Pain Syndrome (CRPS) is usually inadequate. Sympathetic nerve blocks with local anesthetics are commonly employed and in some cases can be an effective option. Nerve blocks are not consistently effective, however, and their utility is further compromised by a short duration of relief.

CRPS is among the pain etiologies that can be managed via Spinal Cord Stimulation (SCS); this option can be quite effective at providing long-term pain relief for the management of CRPS. Importantly, SCS is not usually attempted until other treatment options, including nerve blocks and ablative procedures, have failed to produce adequate pain relief. No studies have been performed to date comparing SCS to a series of nerve block injections plus physical therapy. In this context, it may be prudent to consider SCS earlier in the treatment continuum. Instead of obliging a CRPS patient to cycle through numerous rounds of injections, optimal clinical pain management may be attained through early implantation of an SCS system. This prospective clinical study will compare the relative efficacy of SCS with that of repeated nerve blocks and physical therapy in a group of subjects with moderate-to-severe CRPS pain.

Patients who have never had invasive treatments for CRPS pain will be randomized to either a series of sympathetic blocks plus physical therapy or SCS. Changes in pain, disability, and quality of life outcomes will be assessed at follow up visits as well as incidence and outcomes of subjects electing to cross over to the alternate treatment option. This study will generate insight into the best pain management strategies for CRPS.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Be diagnosed with chronic CRPS with intractable neuropathic pain of moderate to severe intensity within the last 3-6 months.
  • Have failed initial treatment for CRPS, such as physical therapy alone, oral medications, and/or steroids.
  • Be 18 years of age or older.
  • Be an appropriate candidate for the surgical procedures required for SCS.
  • Be willing and able to comply with all study related procedures and visits.
  • Be capable of reading and understanding patient information materials and giving written informed consent.

Exclusion Criteria:

  • Have had any unsuccessful back or spine surgery that currently causes pain.
  • Have had any treatment for CRPS other than physical therapy, oral medications, or steroids.
  • Have any evidence of neurologic instability.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00414804

Sponsors and Collaborators
Boston Scientific Corporation
Investigators
Principal Investigator: Thomas Simopoulos, MD Beth Israel Deaconess Medical Center
  More Information

Responsible Party: Boston Scientific Corporation ( Lyn Pimentel, Clinical Project Manager )
Study ID Numbers: SCS0805
Study First Received: December 20, 2006
Last Updated: September 4, 2008
ClinicalTrials.gov Identifier: NCT00414804  
Health Authority: United States: Institutional Review Board

Keywords provided by Boston Scientific Corporation:
Pain
Neurostimulation

Study placed in the following topic categories:
Autonomic Nervous System Diseases
Neuromuscular Diseases
Complex Regional Pain Syndromes
Peripheral Nervous System Diseases
Pain

Additional relevant MeSH terms:
Pathologic Processes
Disease
Syndrome
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009